1-6 of 6
Erina Sakamoto, MD, PHD
Close
Sort by
Journal Articles

Azacitidine (AZA) Combination Therapy with Low-Dose AraC for Aggressive Type MDS, Overt AML, and AML Patients

Manabu Hirai, MDPhD, Atsushi Inoue, MD, Mitsuharu Hashimura, MD, Mizuki Aimoto, MD PhD, Erina Sakamoto, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1688.
https://doi.org/10.1182/blood.V126.23.1688.1688
Published: 2015
Journal Articles

Azacitidine (AZA) Combination Therapy with Low-Dose AraC Is Well Tolerated and Highly Effective for MDS with Overt Leukemia

Manabu Hirai, MDPhD, Mizuki Aimoto, MD, Atsushi Inoue, MD, Mitsuharu Hashimura, MD, Erina Sakamoto, MD PhD, Hirohisa Nakamae, Masayuki Hino, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3260.
https://doi.org/10.1182/blood.V124.21.3260.3260
Published: 2014
Journal Articles

A New Strategy Of MDS Treatment With Azacitidine (AZA): Induction With AZA Combined With Low Dose AraC Followed By Maintenance Therapy With AZA

Manabu Hirai, MD, PHD, Takahiko Nakane, M.D., Ph.D., Atsushi Inoue, MD, Mitsuharu Hashimura, MD, Mizuki Aimoto, M.D., Erina Sakamoto, MD, PHD, Hirohisa Nakamae, MD, PhD, Masayuki Hino, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1536.
https://doi.org/10.1182/blood.V122.21.1536.1536
Published: 2013
Journal Articles

Tolerated, Low-Dose Deferasirox: Successful Three Cases of Aplastic Anemia and 34 Cases of MDS

Manabu Hirai, MD, PHD, Ryousuke Yamamura, MD, PHD, Hirohisa Nakamae, MD, PhD, Yoshiki Terada, MD., PhD., Atsushi Inoue, MD, Mitsuharu Hashimura, MD, Hiroyoshi Ichihara, MD, PHD, Erina Sakamoto, MD, PHD, Masayuki Hino
Journal: Blood
Blood (2012) 120 (21): 1187.
https://doi.org/10.1182/blood.V120.21.1187.1187
Published: 2012
Journal Articles

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, MD, PhD, Ran Moriguchi, MD, Hiroshi Kanashima, MD, PhD, Erina Sakamoto, MD, PhD, Dai Momose, MD, Mizuki Aimoto, MD, Shuichirou Okamoto, MD, Eri Wada, MD, Hideo Koh, MD, Takahiko Nakane, MD, Yasunobu Takeoka, MD, Ki- Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Yoshitaka Nakao, MD, PhD, Kensuke Ohta, MD, PhD, Atsuko Mugitani, MD, PhD, Hirofumi Teshima, MD, PhD, Masayuki Hino, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4931.
https://doi.org/10.1182/blood.V112.11.4931.4931
Published: 2008
Journal Articles

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Hirohisa Nakamae, MD, PhD, Takahisa Yamane, MD, PhD, Hagihara Kiyoyuki, MD., PhD., Yasunobu Takeoka, MD., Erina Sakamoto, MD., PhD., Takahiko Nakane, MD., Mika Nakamae, MD., PhD., Ki-Ryang Koh, MD., PhD., Kensuke Ohta, MD., PhD., Masayuki Hino, MD., PhD.
Journal: Blood
Blood (2005) 106 (11): 1775.
https://doi.org/10.1182/blood.V106.11.1775.1775
Published: 2005